CLINICAL_TRIALS
trial_result
· 2020-08-10
Clinical Trial Update: Riluzole Oral Soluble Film (ROSF) Swallowing Safety in Amyotrophic Lateral Sclerosis (ALS) [Phase 2]
Summary
A Phase 2 trial evaluating the swallowing safety of riluzole oral soluble film in ALS was terminated with results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Aquestive Therapeutics | Conditions: Amyotrophic Lateral Sclerosis | Phase 2 | Status: TERMINATED | Results posted: 2020-08-10